TRAVERE THERAPEUTICS, INC. (TVTX) Operating margin 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.8%FY2025 · since FY2016: -43.6% → -12.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -12.8% | +126.1 pp |
| FY2024 | -138.9% | +128.4 pp |
| FY2023 | -267.2% | +24.9 pp |
| FY2022 | -292.2% | -140.9 pp |
| FY2021 | -151.3% | -62.4 pp |
| FY2020 | -88.8% | -10.5 pp |
| FY2019 | -78.3% | -29.6 pp |
| FY2018 | -48.7% | -14.0 pp |
| FY2017 | -34.7% | +8.9 pp |
| FY2016 | -43.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TVTX financial trends
TVTX RevenueTVTX Net incomeTVTX Net marginTVTX Gross profitTVTX Gross marginTVTX Operating incomeTVTX Operating cash flowTVTX Free cash flowTVTX Capital expendituresTVTX Return on equityTVTX Stock buybacksTVTX Dividends paidTVTX Total assetsTVTX Total liabilitiesTVTX Shareholders’ equityTVTX overview →